VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Kymera Therapeutics, Inc. (KYMR) Total Return Calculator with Dividends Reinvested

Kymera Therapeutics, Inc.

Popular:

The total return for Kymera Therapeutics, Inc. (KYMR) stock is +146.31% over the past 12 months. So far it's up 13.68% this year. The 5-year total return is +100.56%, meaning $10,000 invested in KYMR stock 5 years ago would be worth $20,056 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in KYMR 1 year ago, it would be worth $28,950 today — you'd have gained $18,950.

With Dividends Reinvested$28,950+189.50%

Price Only (No DRIP)$28,950+189.50%

Period2025-05-06 → 2026-05-05

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in KYMR

1Y$24,631+$14,631 (+146.3%)146.3% CAGR

3Y$28,511+$18,511 (+185.1%)41.8% CAGR

5Y$20,056+$10,056 (+100.6%)14.9% CAGR

10Y$24,868+$14,868 (+148.7%)9.5% CAGR

15Y$24,868+$14,868 (+148.7%)6.3% CAGR

20Y$24,868+$14,868 (+148.7%)4.7% CAGR

30Y$24,868+$14,868 (+148.7%)3.1% CAGR

Kymera Therapeutics, Inc. did not pay dividends during this period. Total return = price return.

Loading KYMR total return...

As of 2026-05-06

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+13.68%	—	+13.68%	—	$11,368
1Y	+146.31%	146.31%	+146.31%	—	$24,631
3Y	+185.11%	41.80%	+185.11%	—	$28,511
5Y	+100.56%	14.93%	+100.56%	—	$20,056
10Y	+148.68%	9.54%	+148.68%	—	$24,868
15Y	+148.68%	6.26%	+148.68%	—	$24,868
20Y	+148.68%	4.66%	+148.68%	—	$24,868
30Y	+148.68%	3.08%	+148.68%	—	$24,868

Risk & Highlights

Best Year+90.29%2025

Worst Year-61.41%2022

Max Drawdown-27.74%2025-12-08 → 2026-01-20 · Recovered 2026-02-26

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+25.55%	+25.55%	—	+0.41%	+25.1pp
2025	+90.29%	+90.29%	—	+16.64%	+73.7pp
2024	+58.70%	+58.70%	—	+24.00%	+34.7pp
2023	+2.50%	+2.50%	—	+24.81%	-22.3pp
2022	-61.41%	-61.41%	—	-19.95%	-41.5pp

KYMR outperformed the S&P 500 by 117.87pp over the past year (+146.31% vs +28.44%).

Loading summary...

KYMR Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
KYMRKymera Therapeutics, Inc.	$6.8B	-3.0%	+13.7%	+146.3%	—	+185.1%	+100.6%	+148.7%
ARVNArvinas, Inc.	$679M	-5.4%	-7.5%	+39.1%	—	-58.1%	-84.2%	-33.9%
PRAXPraxis Precision Medicines, Inc.	$7.5B	+7.5%	+16.4%	+755.5%	—	+1938.5%	-15.6%	-20.1%
VKTXViking Therapeutics, Inc.	$3.6B	-7.7%	-11.6%	+6.2%	—	+37.0%	+427.1%	+2404.8%
BEAMBeam Therapeutics Inc.	$3.0B	+19.3%	+6.5%	+45.8%	—	-14.1%	-60.5%	+54.1%
IMVTImmunovant, Inc.	$5.7B	+11.9%	+7.4%	+82.9%	—	+45.0%	+69.8%	+179.8%
ARQTArcutis Biotherapeutics, Inc.	$2.9B	-1.0%	-19.2%	+52.0%	—	+60.9%	-30.2%	+7.4%
RCUSArcus Biosciences, Inc.	$2.6B	+17.2%	+11.9%	+191.5%	—	+33.2%	-15.8%	+53.3%
PTGXProtagonist Therapeutics, Inc.	$6.2B	-3.5%	+13.9%	+124.2%	—	+300.2%	+241.2%	+748.5%
SNYSanofi	$104.7B	-8.9%	-6.4%	-13.3%	+7.3pp	-8.1%	+5.4%	+63.2%
BMYBristol-Myers Squibb Company	$116.2B	-4.1%	+8.8%	+18.7%	+5.0pp	-5.8%	+5.9%	+8.0%

Compare:KYMR vs ARVN KYMR vs PRAX KYMR vs VKTX KYMR vs ARVN vs PRAX

About KYMR Dividend Returns

Kymera Therapeutics, Inc. (KYMR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of KYMR over the past year?

Kymera Therapeutics, Inc. (KYMR) delivered a return of 146.31% over the past year. Since KYMR does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in KYMR be worth today?

A $10,000 investment in Kymera Therapeutics, Inc. one year ago would be worth $24,631 today, representing a gain of $14,631.

Q3Does KYMR pay dividends?

Kymera Therapeutics, Inc. (KYMR) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For KYMR, the total return equals the price-only return.

Q4Did KYMR beat the S&P 500?

Yes, Kymera Therapeutics, Inc. (KYMR) outperformed the S&P 500 by 117.87 percentage points over the past year. KYMR delivered a total return of 146.31%, compared to the S&P 500's 28.44%. This 117.87pp alpha means investors in KYMR earned more than a passive S&P 500 index fund.

Q5What is KYMR's worst drawdown?

Kymera Therapeutics, Inc. (KYMR) experienced a maximum drawdown of -27.74% over the past year, declining from its peak on 2025-12-08 to its trough on 2026-01-20. The stock recovered to its prior peak by 2026-02-26. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is KYMR's long-term total return over 10, 20, or 30 years?

Here are Kymera Therapeutics, Inc. (KYMR)'s long-term returns with dividends reinvested. Over 10 years, the total return is 148.7% (9.5% CAGR) — $10,000 would have grown to $24,868. Over 20 years: 148.7% total return (4.7% CAGR) — $10,000 → $24,868. Over 30 years: 148.7% total return (3.1% CAGR) — $10,000 → $24,868. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was KYMR's best and worst year?

Kymera Therapeutics, Inc.'s best calendar year was 2025 with a total return of 90.3%. Its worst year was 2022 with a total return of -61.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 151.7 percentage points.